- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01314040
Study to Identify Biomarkers for Protein Intake (Biomarker)
May 30, 2011 updated by: Wageningen University
Study to Identify Biomarkers for Protein Intake; a Randomized, Fully Controlled Feeding Study
Results from observational studies suggest a small beneficial association between protein and blood pressure that may be mainly attributable to the intake of protein from plant sources.
In epidemiological studies biomarkers of dietary intake are useful to estimate intake more reliably.
Dietary studies using biomarkers of protein intake generally show stronger associations with health outcomes.
However, data on biomarkers for specific types of protein (e.g. from dairy, meat, grain and legumes) are scarce.
Therefore the purpose of this study is to identify new biomarkers for the intake of protein from meat, dairy and grain.
In addition the secondary purpose is to investigate whether intake of protein from these sources influences kidney filtration rate and urinary acid excretion differentially.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
25
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gelderland
-
Wageningen, Gelderland, Netherlands, 6700 EV
- Wageningen University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 18-40 years
- BMI between 18.5 and 30 kg/m2
- Healthy (As judged by the participant)
- Written informed consent obtained
Exclusion Criteria:
- Unable or unwilling to comply with study procedures.
- Unusual dietary patterns, including high alcohol intakes (≥ 2 glasses/day) and a vegetarian diet
- Recent (< 4 weeks) or current participation in a study with any investigational drug or dietary intervention
- Usage of an energy restricted diet during the last two months
- Weight loss or weight gain of 5 kg or more during the last two months
- Smoking
- Stomach or bowel diseases
- Kidney disorders
- Diabetes, thyroid disease, other endocrine disorders
- Prevalent cardiovascular disease
- Extreme sports (>8h/ wk)
- Usage of any prescribed medication except for oral contraceptives
- Use of systemic antibiotics in the period of 3 month prior to the study
- For women: pregnant or lactating
- For women: not using oral contraceptives
- For women: Unwilling to use oral contraceptives for consecutively for at least the total study duration
- Liver function parameters (ALAT, ASAT, and γ-GT) and renal function parameters (Serum creatinin) outside the normal range
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Run in
|
Fully controlled dietary period during 9 days.
Participants will receive approximately 15 en% of protein.
The amount of protein intake from dairy, meat, and grain will be equal to each other
|
Experimental: High meat protein diet
|
Fully controlled diet during 7 days.
Participants will consume 18 en% protein, mainly from meat.
|
Experimental: High dairy protein diet
|
Fully controlled dietary intervention during 7 days.
Participants will consume 20 en% protein.
Mainly from dairy
|
Experimental: High grain protein diet
|
Fully controlled dietary intervention for 7 days.
Participants will consume 20 en% of protein.
Mainly from grain
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Differences between dietary periods in concentrations of potential biomerkers in blood and urine
Time Frame: On the last day of every one week intervention period
|
Potential biomarkers that will be measured are urinary creatinin, sulphate, carnosine, 1-MH, 3-MH, taurine,14N/15N and creatin in blood.
Furthermore, amino acid profiling will be done in blood and urine to detect differences between dietary periods
|
On the last day of every one week intervention period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Differences between dietary period in estimated renal filtration
Time Frame: blood and urine collection on the last day of each intervention period
|
Renal filtration will be estimated using bromide distribution in combination with bio-impedance measurement
|
blood and urine collection on the last day of each intervention period
|
Differences between dietary periods in urinary acid excretion
Time Frame: urine collection on the last day of each intervention period
|
urine collection on the last day of each intervention period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2011
Primary Completion (Actual)
April 1, 2011
Study Completion (Actual)
April 1, 2011
Study Registration Dates
First Submitted
February 25, 2011
First Submitted That Met QC Criteria
March 10, 2011
First Posted (Estimate)
March 14, 2011
Study Record Updates
Last Update Posted (Estimate)
June 1, 2011
Last Update Submitted That Met QC Criteria
May 30, 2011
Last Verified
May 1, 2011
More Information
Terms related to this study
Other Study ID Numbers
- A1003/ WP-B1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Identify New Biomarkers in Blood or Urine After Consumption of Meat Protein, Dairy Protein and Grain Protein in Healthy Subjects.
-
Centre Hospitalier Régional de la CitadelleSanofi; Takeda; University of Liege; Orchard Therapeutics; Centre Hospitalier Universitaire... and other collaboratorsRecruitingCongenital Adrenal Hyperplasia | Hemophilia A | Hemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis II | Cystic Fibrosis | Alpha 1-Antitrypsin Deficiency | Sickle Cell Disease | Fanconi Anemia | Chronic Granulomatous Disease | Wilson Disease | Severe Congenital Neutropenia | Ornithine Transcarbamylase... and other conditionsBelgium
Clinical Trials on Run in diet
-
GlaxoSmithKlineCompleted
-
University of Colorado, DenverCompleted
-
University of PittsburghAgency for Healthcare Research and Quality (AHRQ)RecruitingCritical Care | Health Services | Transitional Care | Post-intensive Care SyndromeUnited States
-
Centre Hospitalier Annecy GenevoisWithdrawnCognition Disorders | Fall Injury | Dependence | Fall From Bed | Fall in Nursing HomeFrance
-
Guy's and St Thomas' NHS Foundation TrustB&D ElectromedicalCompletedExcessive Dynamic Airway Collapse | TracheobronchomalaciaUnited Kingdom
-
Sahlgrenska University Hospital, SwedenCompletedIrritable Bowel SyndromeSweden
-
Universidade Cidade de Sao PauloCompleted
-
Massachusetts General HospitalActive, not recruitingNon Small Cell Lung Cancer | Mesothelioma | Small-cell Lung Cancer | Cognitive Behavioral TherapyUnited States
-
University of StellenboschNestlè Nutrition Institute Africa; National Research Foundation (NRF) (RSA)CompletedIrritable Bowel SyndromeSouth Africa
-
Jiangsu HengRui Medicine Co., Ltd.Completed